OLIVIA CZERNIAK: Open Payments
NPI 1376294462 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,125 in 14 payments from 7 companies in 2025. Trend: 2023 $694 · 2024 $1,268 · 2025 $1,125
Food & beverage: $1,025Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $693 |
| E.R. Squibb & Sons, L.L.C. | 2 | $148 |
| GENZYME CORPORATION | 1 | $114 |
| Stemline Therapeutics Inc. | 1 | $69 |
| Pharmacosmos Therapeutics Inc. | 1 | $43 |
| Merck Sharp & Dohme LLC | 2 | $30 |
| Tempus AI, Inc | 1 | $27 |
Products named: RYBREVANT, TECVAYLI, OPDIVO, WAYRILZ, DARZALEX, ELZONRIS, MONOFERRIC, KEYTRUDA.
Industry payments across IN — which companies pay providers there.
